Literature DB >> 8851494

Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter.

M La1, C G Li, M J Rand.   

Abstract

1. The effects of ranges of concentrations of oxyhaemoglobin (0.01-30 microM) and hydroxocobalamin (1-100 microM) were compared for their abilities to reduce relaxant responses to EDRF released by acetylcholine in endothelium-intact rat aortic rings, the nitergic transmitter in rat anococcygeus muscles, and NO in aqueous solution in both tissues (aortic rings were denuded of endothelium). 2. The concentrations of oxyhaemoglobin producing 50% reduction of responses to EDRF and NO in rat aorta correspond closely, the IC50 values being 0.13 +/- 0.02 microM and 0.11 +/- 0.02 microM respectively. 3. Oxyhaemoglobin was equally effective in inhibiting responses to NO in anococcygeus muscles and in aortic rings with an IC50 of 0.14 +/- 0.05 microM. However, responses to the nitrergic transmitter were considerably less sensitive to inhibition by oxyhaemoglobin, the IC50 being 19.7 +/- 5.1 microM. 4. The IC50 values for hydroxocobalamin in inhibiting responses to EDRF and NO in aorta were 3.4 +/- 0.2 microM and 8.4 +/- 0.63 microM, respectively, but it was less effective against responses to NO in anococcygeus muscles the IC50 being 46 +/- 9.6 microM. However, even in the highest concentration used (100 microM), it did not reduce responses to the nitrergic transmitter. 5. The findings are compatible with the views that EDRF is NO, but suggest that the nitergic transmitter in the rat anococcygeus muscle does not behave like free NO.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851494      PMCID: PMC1909394          DOI: 10.1111/j.1476-5381.1996.tb15264.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  A comparison of haemoglobin and erythrocytes as inhibitors of smooth muscle relaxation by the NANC transmitter in the BRP and rat anococcygeus and by EDRF in the rabbit aortic strip.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.

Authors:  P R Myers; R L Minor; R Guerra; J N Bates; D G Harrison
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

3.  Block of some non-adrenergic inhibitory responses of smooth muscle by a substance from haemolysed erythrocytes.

Authors:  A Bowman; J S Gillespie
Journal:  J Physiol       Date:  1982-07       Impact factor: 5.182

4.  Oxyhaemoglobin blocks non-adrenergic non-cholinergic inhibition in the bovine retractor penis muscle.

Authors:  A Bowman; J S Gillespie; D Pollock
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

5.  The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

6.  Control of coronary vascular tone by nitric oxide.

Authors:  M Kelm; J Schrader
Journal:  Circ Res       Date:  1990-06       Impact factor: 17.367

7.  Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle.

Authors:  C G Li; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1989-12       Impact factor: 2.557

8.  Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

9.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

10.  The rat anococcygeus muscle and its response to nerve stimulation and to some drugs.

Authors:  J S Gillespie
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  8 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles.

Authors:  C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Spontaneous photo-relaxation of urethral smooth muscle from sheep, pig and rat and its relationship with nitrergic neurotransmission.

Authors:  D Triguero; G Costa; A Labadía; E Jiménez; A García-Pascual
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

5.  Effects of superoxide anion generators and thiol modulators on nitrergic transmission and relaxation to exogenous nitric oxide in the sheep urethra.

Authors:  A Garcia-Pascual; A Labadia; G Costa; D Triguero
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

6.  Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt.

Authors:  A Ellis; H Lu; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion.

Authors:  J C Wanstall; T K Jeffery; A Gambino; F Lovren; C R Triggle
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).

Authors:  Lesley J Bryan-Lluka; Marisa H Papacostas; Filip A Paczkowski; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.